MESO
Price
$12.21
Change
-$0.30 (-2.40%)
Updated
Dec 18, 04:59 PM (EDT)
TNGX
Price
$2.79
Change
-$0.11 (-3.78%)
Updated
Dec 18, 04:59 PM (EDT)
103 days until earnings call
Ad is loading...

MESO vs TNGX

Header iconMESO vs TNGX Comparison
Open Charts MESO vs TNGXBanner chart's image
Mesoblast
Price$12.21
Change-$0.30 (-2.40%)
Volume$3.21K
CapitalizationN/A
Tango Therapeutics
Price$2.79
Change-$0.11 (-3.78%)
Volume$17.34K
CapitalizationN/A
MESO vs TNGX Comparison Chart
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. TNGX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a StrongBuy and TNGX is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (MESO: $12.51 vs. TNGX: $2.91)
Brand notoriety: MESO and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 111% vs. TNGX: 46%
Market capitalization -- MESO: $1.44B vs. TNGX: $312.59M
MESO [@Biotechnology] is valued at $1.44B. TNGX’s [@Biotechnology] market capitalization is $312.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 1 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both MESO and TNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 4 TA indicator(s) are bullish while TNGX’s TA Score has 5 bullish TA indicator(s).

  • MESO’s TA Score: 4 bullish, 4 bearish.
  • TNGX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TNGX is a better buy in the short-term than MESO.

Price Growth

MESO (@Biotechnology) experienced а +11.70% price change this week, while TNGX (@Biotechnology) price change was -12.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

MESO is expected to report earnings on May 30, 2024.

TNGX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.44B) has a higher market cap than TNGX($313M). MESO YTD gains are higher at: 468.636 vs. TNGX (-70.606). MESO has higher annual earnings (EBITDA): -62.82M vs. TNGX (-137.2M). TNGX has more cash in the bank: 293M vs. MESO (62.6M). TNGX has less debt than MESO: TNGX (37.6M) vs MESO (119M). TNGX has higher revenues than MESO: TNGX (43.4M) vs MESO (5.9M).
MESOTNGXMESO / TNGX
Capitalization1.44B313M460%
EBITDA-62.82M-137.2M46%
Gain YTD468.636-70.606-664%
P/E RatioN/AN/A-
Revenue5.9M43.4M14%
Total Cash62.6M293M21%
Total Debt119M37.6M316%
FUNDAMENTALS RATINGS
MESO: Fundamental Ratings
MESO
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MESOTNGX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 22 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMQIX8.17N/A
N/A
Ashmore Emerging Markets Active Eq Instl
AIBBX16.22N/A
N/A
Aristotle Small Cap Equity I-2
USRTX33.61-0.10
-0.30%
Horizon Multi-Factor U.S. Equity Advisor
JIGZX82.02-0.29
-0.35%
JPMorgan U.S. GARP Equity R2
FADTX132.40-0.84
-0.63%
Fidelity Advisor Technology A

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been closely correlated with SAGE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MESO jumps, then SAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+3.39%
SAGE - MESO
66%
Closely correlated
-1.40%
QTTB - MESO
58%
Loosely correlated
-2.00%
VTGN - MESO
48%
Loosely correlated
-2.02%
TNGX - MESO
33%
Poorly correlated
-1.36%
TSVT - MESO
32%
Poorly correlated
-1.53%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-1.36%
AXON - TNGX
41%
Loosely correlated
-2.09%
MDGL - TNGX
39%
Loosely correlated
-1.58%
BNTC - TNGX
36%
Loosely correlated
+1.51%
ORMP - TNGX
36%
Loosely correlated
-1.67%
VERA - TNGX
35%
Loosely correlated
-0.11%
More